Patent application number | Description | Published |
20080261971 | Novel Heterocyclic Nf-Kb Inhibitors - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, (I) wherein R | 10-23-2008 |
20100004258 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (III): | 01-07-2010 |
20100048574 | NOVEL HETEROCYCLIC NF-kB INHIBITORS - The present invention relates to compounds of the general formula (II): | 02-25-2010 |
20100048583 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 02-25-2010 |
20100216772 | Novel Phenantridine Analogues and Uses Thereof - The present invention relates to compounds of the general formula (IV) and (II) and salts and physiologically functional derivatives thereof, | 08-26-2010 |
20100267717 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates in one embodiment to compounds of formula (Ih) and/or a pharmaceutically acceptable salt thereof with an acid or a base, and/or a pharmaceutically acceptable prodrug and/or a stereoisomer thereof, | 10-21-2010 |
20120022068 | NOVEL HETEROCYCLIC NF-kB INHIBITORS - The present invention relates in one embodiment to compounds of formula (Ih) and/or a pharmaceutically acceptable salt thereof with an acid or a base, and/or a pharmaceutically acceptable prodrug and/or a stereoisomer thereof, | 01-26-2012 |